About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, March 18th, 2016

The QualityStocks
Daily Stock List


Global Future City Holding, Inc. (FTCY)

SmallCapVoice reported recently on Global Future City Holding, Inc. (FTCY), TopPennyStockMovers did previously, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Global Future City Holding, Inc. is a holding company with corporate headquarters in Irvine, California. The Company focuses on implementing an EB-5 immigrant investor program for foreign investors who are interested in acquiring lawful permanent residence in the U.S. and the marketing and deployment of its loyalty-based membership program. Global Future City Holding’s shares trade on the OTC Markets’ Group’s OTCQB.

The Company previously went by the name FITT Highway Products, Inc. It changed its name to Global Future City Holding, Inc. in October 2014. GX-Life Global, Inc. is a wholly-owned subsidiary of Global Future City Holding. Moreover, F.I.T.T. Energy Products, Inc. is a subsidiary of Global Future City Holding. F.I.T.T.  produces, distributes, and sells energy supplements.

The Company’s intention is to focus its first efforts on acquiring qualified investment projects aligned with its EB-5 Regional Center and launching the digital currency-based membership program. Global Future City Regional Center, LLC is an EB-5 Regional Center designated by the USCIS.   

Because of recent transactions with GX-Life Global, Inc. and the acquisition of a designated EB-5 regional center approved by the U.S. Citizen and Immigration Service (EB-5 Subsidiary), the Company’s intention is to expand its operations into a number of new areas. One emphasis will be to obtain real estate projects, which will fit the purchase of the recently acquired EB-5 Subsidiary. Another emphasis will be the development of a loyalty-based reward program using a digital security.

GX-Life Global is working on developing a strong, scalable platform to support its membership program worldwide. GX-Life Global is supported by “GX-Coins”. This is a digital currency that functions as a store of value and a medium of exchange.

GX-Life Global’s plan is to deploy the GX-Coins it obtains from Great Coin, Inc. by distributing them to members of its membership program community as loyalty points for the members’ participation in the membership program. Great Coin (a Nevada corporation) is a technology enterprise. Great Coin is in the process of developing “Great Coin” or “GX-Coin” - a digital currency.

Global Future City Holding announced this week that Great Coin, its strategic partner wholly-owned by the officers and directors of the Company, started accepting wallet applications starting March 15, 2016. Great Coin’s trading platform will launch soon after the registration of the wallet applications.

Great Coin entered into a Technology License with GX-Life Global. Under the Technology License, qualifying members of Global Future City Holding’s marketing program will be able to trade GX-Coin digital currency on Great Coin’s proprietary platform licensed under the Technology License. Furthermore, Great Coin is finalizing the technical and regulatory ability to trade in Asia.

Global Future City Holding, Inc. (FTCY), closed Friday's trading session at $3.64, even for the day, on 4,065 volume with 8 trades. The average volume for the last 60 days is 14,090 and the stock's 52-week low/high is $0.204/$3.70.

MabVax Therapeutics Holdings, Inc. (MBVX)

PennyStockRumors.net and TopPennyStockMovers reported previously on MabVax Therapeutics Holdings, Inc. (MBVX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MabVax Therapeutics Holdings, Inc. is a cancer diagnostic and Immunotherapy Company listed on the OTCQB. It focuses on the development of vaccine and antibody-based products and vaccines to address unmet medical needs in the treatment of cancer. The Company’s lead antibody candidate HuMab 5B1 is undergoing development as both a diagnostic product and therapeutic agent for the diagnosis and treatment of GI cancers and specifically pancreatic cancer. A clinical stage oncology drug development company, MabVax Therapeutics Holdings has its headquarters in San Diego, California.

The Company has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers with MabVax’s proprietary vaccines. MabVax generates its pipeline of antibody based product candidates from patients who have been vaccinated with the proprietary vaccines MabVax has licensed from Memorial Sloan-Kettering Cancer Center (MSKCC).

The Company’s therapeutic vaccines were developed at MSKCC and exclusively licensed to MabVax. The vaccines are administered in the adjuvant setting and provoke a protective antibody response. The antibodies search out circulating tumor cells and micrometastases to kill them before they can cause cancer recurrence.

MabVax Therapeutics has two cancer vaccines targeting recurrent sarcoma and ovarian cancer in proof-of-concept Phase II multicenter clinical trials, and a vaccine targeting neuroblastoma, which will be ready for a Phase II clinical trial this year.

Recently, MabVax Therapeutics announced receipt of notice from the U.S. Food and Drug Administration (FDA) authorizing initiation of a Phase I clinical trial with 89Zr-HuMab-5B1 as a new generation PET scan cancer imaging agent in patients with pancreatic cancer. MabVax filed an Investigational New Drug (IND) application for this trial with the FDA on December 29, 2015.

The Company previously announced receipt of FDA authorization for a Phase I trial with HuMab-5B1 as a therapeutic treatment for patients with pancreatic cancer. The expectation is that patient enrollment in both Phase I trials will start in this first quarter of 2016.

MabVax Therapeutics Holdings, Inc. (MBVX), closed Friday's trading session at $0.79, up 12.86%, on 122,591 volume with 53 trades. The average volume for the last 60 days is 50,416 and the stock's 52-week low/high is $0.41/$4.94.

Claude Resources, Inc. (CLGRF)

Zacks reported earlier on Claude Resources, Inc. (CLGRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Claude Resources, Inc. is a gold exploration and mining enterprise based in Saskatoon, Saskatchewan. The Company is a gold producer and also engages in the exploration and development of gold mineral reserves and mineral resources. Since 1991, it has produced in excess of 1,000,000 ounces of gold from its Seabee Gold Operation in northeastern Saskatchewan. In addition, the Company owns 100 percent of the Amisk Gold Project in northeastern Saskatchewan. Claude Resources lists on the OTC Markets’ OTCQB.

The Company’s Seabee Gold operation consists of two producing mines. These are the Seabee Gold Mine and the Santoy 8 Gold Mine. The Seabee Gold Operation is in the La Ronge Mining District at the north end of Laonil Lake around 125 kilometers northeast of the town of La Ronge, Saskatchewan and roughly 150 kilometers northwest of Flin Flon, Manitoba.

The Santoy Lake property is an 11,400 acre (4,566 hectare) claim group. It is adjacent to the Claude/Currie Rose property, approximately 14 kilometers east of the Company’s operating Seabee Mine. Claude’s Amisk Gold Project is in Saskatchewan near Flin Flon, Manitoba. The property comprises 40,373 hectares.

Claude Resources announced in June 2015 that it expanded its land position by around 3,000 hectares to 19,950 hectares at the Seabee Gold Operation in northeastern Saskatchewan. The additional 3,000 hectares are east and north of the Santoy region where Claude Resources is now increasing production from the Santoy Mine Complex (Santoy Gap and Santoy 8).

As well, the Company purchased its only two joint venture (JV) agreements on the property from Karoo Exploration Corp. and Star Minerals Group Ltd. The Karoo JV agreement, consisting of 65 hectares, was purchased for 73,529 common shares of Claude Resources.

The Star JV agreement, consisting of 642 hectares, was purchased for 134,664 common shares of Claude Resources. Through acquiring these two JVs, the Company now owns and controls 100 percent of the entire gold belt and land package within the Seabee Gold Operation.

On March 7, 2016, Silver Standard Resources, Inc. (SSRI) and Claude Resources announced that they entered into a definitive agreement. Silver Standard will acquire all of the outstanding common shares of Claude Resources pursuant to a plan of arrangement to create a high-quality intermediate precious metals producer with assets in the Americas.

This week, Claude Resources announced continued positive results from its 2015 underground and recently started 2016 surface drill programs at its 100 percent owned Santoy Mine Complex. Moreover, it announced an 83,000-meter drill program at the Seabee Gold Operation for 2016.

Claude Resources, Inc. (CLGRF), closed Friday's trading session at $1.04, up 2.97%, on 260,181 volume with 176 trades. The average volume for the last 60 days is 226,837 and the stock's 52-week low/high is $0.3897/$1.174.

Arch Therapeutics, Inc. (ARTH)

Stock Gumshoe, Jet-Life Penny Stocks, Hot Stock Profits, Equity Observer, and Wall Street Resources reported recently on Arch Therapeutics, Inc. (ARTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. The Company’s aim is to develop and commercialize products based on its pioneering technology platform. The platform makes surgery and interventional care quicker and safer for patients. The underlying technology, exclusively licensed from a leading university, supports a leading-edge platform of smart materials, which fulfill the criteria as a solution for a specialized field the Company calls, “stasis and barrier applications.” Arch Therapeutics is headquartered in Framingham, Massachusetts.

Arch’s flagship development stage product candidate is named AC5™ (AC5 Surgical Hemostatic Device™). This is a synthetic peptide consisting of naturally occurring amino acids. AC5™ is undergoing design to smoothly achieve hemostasis in minimally invasive (laparoscopic) and open surgical procedures. Its solution smartly controls the movement of fluids and substances. AC5™ stops bleeding fast. AC5™ conforms to irregular wound geometry and helps in maintaining a clear field of vision directly into the wound area.

AC5™, when squirted or sprayed onto a wound, quickly intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances (including blood and other bodily fluids) irrespective of kind of surgery or, based on early data, clotting ability, and healing occurs normally. The Company indicates that in preclinical tests, AC5™ has been simple, effective, and versatile.  

This week, Arch Therapeutics announced that it obtained favorable results from a broad panel of preclinical biocompatibility tests performed on AC5, which is required before the planned filing of a CE Mark application and commercialization of AC5 in Europe. Results from these biocompatibility safety studies indicate that AC5's peptide structure and mechanism of action (based on the formation of a local physical-mechanical barrier at the wound site) does not promote toxicity to the overall biological system following exposure to AC5.

Arch Therapeutics, Inc. (ARTH), closed Friday's trading session at $0.212, up 7.61%, on 584,780 volume with 55 trades. The average volume for the last 60 days is 243,043 and the stock's 52-week low/high is $0.1632/$0.391.

AXIM Biotechnologies, Inc. (AXIM)

SmallCapVoice reported previously on AXIM Biotechnologies, Inc. (AXIM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2010, AXIM Biotechnologies, Inc. is a biotechnology company centering on the research, development, and production of pharmaceutical, nutraceutical, and cosmetic products. The Company previously went by the name Axim International, Inc. It changed its name to AXIM Biotechnologies, Inc. in July of 2014. AXIM Biotechnologies is based in New York City.

The Company is building a state-of-the-art manufacturing facility in Almere, The Netherlands. Upon completion, this facility will include manufacturing in the Pharmaceuticals, Nutraceuticals, Functional Foods, Cosmetics, as well as Clean Energy product categories.

AXIM Biotechnologies discovers and brings to market unique solutions by way of research and development, strategic partnerships, and acquisitions by setting the green standard in the industrial hemp industry. Going forward, the intention of AXIM’s Board of Directors is to increase the present operations of the Company to include pharmaceutical products, manufacturing facilities, genetically controlled botanical products, extraction and purification of bio-materials technologies.

AXIM Biotechnologies’ emphasis is on innovative proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is at present no effective treatment. Currently, these indications include MS, spasticity, pain, Parkinson’s disease, Alzheimer’s disease/dementia, ADHD (attention deficit hyperactivity disorder), psychosis, PTSD, autism, RLS (restless leg syndrome), glaucoma, IBD, IBS, as well as Crohn’s disease.

The Company’s pioneering invention on track to be fully registered by the EMA and FDA by the end of 2017 is the world’s first patented cannabinoid controlled-release chewing gum, called MedChew Rx™.

AXIM Biotechnologies’ pipeline of intellectual property (IP) protected cannabinoid-based products include the above-mentioned MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. The Company’s products also include RENECANN™, which is the world’s first cannabigerol (CBG)-based skincare product line.

Its products also include ORAXIMAX™, which is the world’s first CBG-based oral care product line; Suppocann™ - a suppository cannabinoid-release product for GI conditions including IBD, IBS and Crohn’s disease; and Ophthocann™ and Cannbleph™ - cannabinoid-based products for the reduction of intraocular pressure and for relief of conjunctivitis.

AXIM Biotechnologies, Inc. (AXIM), closed Friday's trading session at $0.60, even for the day, on 8,702 volume with 8 trades. The average volume for the last 60 days is 5,881 and the stock's 52-week low/high is $0.061/$1.30.


The QualityStocks
Company Corner


Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0185, even for the day, on 1,414,604 volume with 52 trades. The stock’s average daily volume over the past 60 days is 1,398,010 and its 52-week low/high is $0.0035/$0.339.

Dominovas Energy Corp. announces the Company's inclusion in a seminal report on the advancements and progress made in commercializing applications for fuel cell technology, as a viable source for both baseload and back-up power generation. The report, State of the States: Fuel Cells in America 2015, was written and compiled by the Fuel Cell and Hydrogen Energy Association (FCHEA) with support from the U.S. Department of Energy's Office of Energy Efficiency and Renewable Energy's Fuel Cell Technologies Office.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Recognized as Leader in Expanding Fuel Cell Applications in U.S. Department of Energy (DOE) Report

Dominovas Energy Agrees to Acquire Grupo Trebol in Guatemala City, Guatemala

Dominovas Energy Signs Financing Agreement With GHS Capital

Alternet Systems, Inc. (ALYI)

The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.014, up 55.56%, on 313,973 volume with 26 trades. The stock’s average daily volume over the past 60 days is 76,924, and its 52-week low/high is $0.0055/$0.0349.

Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets

Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.

Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.

With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.

As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer

Alternet Systems, Inc. Company Blog

Alternet Systems, Inc. News:

Alternet Systems Data Analytics Solution Gains Momentum with New Clients and Partners

Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation

Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base

Giggles N' Hugs, Inc. (GIGL)

The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.08, up 14.29%, on 19,524 volume with 6 trades. The stock’s average daily volume over the past 60 days is 38,860, and its 52-week low/high is $0.0137/$0.2999.

Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.

Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.

Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer

Giggles N' Hugs, Inc. Company Blog

Giggles N' Hugs, Inc. News:

Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview

Giggles N’ Hugs Signs Agreement with New York-Based Chardan Capital Markets

Giggles N Hugs to present at the 8th annual LD Micro Conference main event

Star Mountain Resources, Inc. (SMRS)

The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $0.65, even for the day, on 17,100 volume with 4 trades. The stock’s average daily volume over the past 60 days is 7,775, and its 52-week low/high is $0.35/$1.40.

Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.

Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.

The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.

Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer

Star Mountain Resources, Inc. Company Blog

Star Mountain Resources, Inc. News:

Star Mountain Resources Receives Industry Guide 7 Mineral Reserves Report on Balmat Mine

Star Mountain Resources, Inc. Closes Acquisition of Balmat Zinc Mine in New York State

Star Mountain Resources, Inc. to Acquire Balmat Zinc Mine in New York State

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $4.30, even for the day. The stock’s average daily volume over the past 60 days is 843, and its 52-week low/high is $3.92/$6.50.

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate

Moxian, Inc. Covered by Crystal Equity Research

Moxian, Inc. Establishes Beijing Subsidiary, Defines Expansion Plans


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251